Back

Comparison of clinical outcomes with short-term and long-term DAPT after PCI using second-generation drug-eluting stents in high bleeding risk patient : a systematic review and meta-analysis

25 August 2023 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Patients and lesion subsets Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Ryan Enast Intan

Dr. Soetomo General Hospital, Surabaya (Indonesia)

7 More presentations in this session

Presentation thumbnail
Percutaneous treatment of left main coronary artery disease - temporal trends from large registry and ten-year follow-up. a single centre experience.
Doctor E. Dabrowski (Bialystok, PL)
Abstract Slides Video
Presentation thumbnail
Side branch closure in patients undergoing coronary bifurcation stenting with or without side branch predilatation
Professor D. Vassilev (Ruse, BG)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on mortality of patients undergoing bifurcation PCI
Professor D. Vassilev (Ruse, BG)
Abstract Slides Video
Presentation thumbnail
A novel scoring system devised by an international large-scale coronary bifurcation registry to guide the optimal choice between the 1- and 2-stent strategy: the BIFURCAT Two-Stent (BTS) score
Assistant Professor P. Oh (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Double kissing inflation outside the stent versus jailed balloon technique for coronary bifurcation lesions
Doctor H. Yang (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Patients and lesion subsets

The Event

Event poster

ESC Congress 2023

25 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy for percutaneous coronary intervention following acute coronary syndrome: a meta-analysis of randomized clinical trials
thumbnail
Congress Presentation
Meta-analysis of 3-month vs 12-month dual anti-platelet therapy after percutaneous coronary intervention
thumbnail
Congress Presentation
A very short duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources